Industry: Biological Region: Spain Transaction price: US$ 1 million Transaction method: equity investment
Project introduction:
A Spanish company, founded in 2001, provides all-round bioanalysis and quality control services for small molecule drugs, biological agents and advanced therapies. Committed to providing support to pharmaceutical, biotechnology, generic drugs and similar drugs customers in more than 60 countries around the world, helping their product development, reducing costs and shortening time to market. With its unique customized scheme and interdisciplinary understanding of the whole R&D and production process, the company provides customers with all-round services: from early R&D, product development, pre-clinical research and clinical trial stage to approval and post-marketing regulatory requirements.
Services provided by enterprises:
1. Pre-clinical and clinical biological analysis
The company is in the leading position in the field of biological analysis, providing accurate and reliable detection solutions for every stage of drug development. The service covers biological analysis of small molecules, biological agents and advanced therapies, bioequivalence research, biomarker analysis, pharmacokinetic evaluation, biological distribution and immunogenicity research, aiming at ensuring compliance with GLP and GCP specifications.
2. CMC analysis and quality control
The company's services cover method development and verification, quality control, stability research, comparability analysis of similar biological drugs and batch release, and adopt advanced analytical techniques and methods.
Cooperation mode:
Seek the partners who need bio-analysis and CMC services in China.